About Us

Ra Medical Systems was founded in 2002 by Dean Irwin and Melissa Burstein to design, develop, and commercialize excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its flagship product, Pharos, launched in 2004 and revolutionized the dermatology world with its technological advancements and game-changing business model of affordable ownership with unlimited use.

Staying true to the values upon which the company was founded, Ra Medical Systems continued to be a private, clinically-oriented, scientifically-driven organization, focusing on self-funding its growth organically and sustainably. Maintaining profitability year after year by strategic cost management while exponentially growing revenue from Pharos laser sales in the US and internationally, profits were reinvested internally to fund the development of its cardiovascular laser and catheters.

In 2012, the first patients were treated with Ra Medical Systems’ cardiovascular DABRA catheter and laser system in a pilot study conducted outside the United States.

Over the past decade, Pharos has helped hundreds of thousands of patients triumph over difficult-to-treat skin diseases and gain more confidence in their appearance and themselves. Ra Medical Systems’ Pharos has transformed their lives.

Request a Call Back

Let us know how to get back to you.

Our Pledge To You

We, Ra Medical Systems, pledge to provide the highest quality, innovative technology that improves patients’ lives. We will do so with honesty and integrity, transparency in our actions, accountability for our products, and mindfulness of our responsibilities to our customers, their patients, and our shareholders.

A Legacy of Innovation

Ra Medical Systems was founded on three fundamental beliefs:

  • Excimer laser medicine could save and change lives for the better.
  • A totally new kind of company, built differently than those before it, could fulfill its potential.
  • The company must merge innovative science with pragmatic entrepreneurship, create a culture of smart, cost-effective decision making and personal accountability, and deliver better, safer, faster, and cheaper lasers and catheters.

This is the company we have built. This is the culture we have created. And this is the mission that drives us forward every day.


    Latest Articles

    • Industry Welcomes Suspension of Device Tax

      HEALTH CARE: Tax Said to Hurt Staffing, R&D Efforts at Cos. San Diego — While San Diego’s medtech hub is cheering the recent suspension of a 2.3 percent excise tax on medical device makers, a full repeal remains the industry’s ultimate goal. A deal that Congress struck... Read More


    • Healthcare Has Healthy Impact on San Diego Real Estate

      Healthcare and related industries continue to exert growing impact on demand for commercial real estate in San Diego County. Among the latest examples is developer Sudberry Properties’ ground-breaking for a second 158,000-square-foot office building at the Scripps Ranch headquarters of client MedImpact Healthcare Systems Inc., a... Read More


    • 24 CEOs and Execs on the Daily Habits That Made Them Successful

      Ra Medical Systems’ CEO, Dean Irwin, has been a part of a trending inspirational article. Originally published by Inc., the article quoted 24 CEOs and executives on their daily habits that have contributed to their success. Irwin’s habit of choice is perseverance! The article is now... Read More


    • Following FDA Approval for PAD, Ra Medical Steps Up Hiring

      Carlsbad, Calif.-based RA Medical Systems closed out 2017 with the launch of its newly approved peripheral artery disease (PAD) treatment. Ra’s DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) system became available to customers in October after receiving a May approval from the U.S. Food and Drug Administration. The company... Read More


    • Medtech Cos. Look to Derail Device Tax

      San Diego — Carlsbad’s Ra Medical Systems is among the medtech companies that say the return of a 2.3 percent excise tax on medical devices sold in the U.S. threatens expansion and hiring plans. Congress failed to deliver on promises to kill the tax, which resumed Jan... Read More